or
forgot password
  • cancer clinical trials in massachusetts

  • Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Esophageal Cancer, Stomach Cancer
    Treatment of Acute Lymphoblastic Leukemia in Children
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Drug/Agent Toxicity by Tissue/Organ, Leukemia
    Exercise Intervention in Women With Metastatic Breast Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Beth Isreal Deaconess Medical Center
    Breast Cancer
    A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
    Site Reference ID/Investigator# 40243
    Boston, Massachusetts 02115
    Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    University of Massachusetts Medical School
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
    Research Site
    Beverly, Massachusetts
    Thyroid Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Breast Cancer, Metastatic Cancer
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    DFCI/Children's Hospital of Boston
    Boston, Massachusetts 02114
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Brigham & Womens Hospital

    Trial Locations
    Brigham & Womens Hospital
    Tufts Medical Center, Inc.
    UMass Memorial Medical Center
    Mycoses, Candidiasis, Invasive, Candidemia
    Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Commonwealth Hematology Oncology PC-Worcester
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation
    DFCI/Partners Cancer Center
    Boston, Massachusetts 02118
    Pneumonia, Idiopathic Pneumonia Syndrome
    Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Waldenstrom's Macroglobulinemia
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Anal Cancer
    A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

    Boston, Massachusetts
    HEPATOCELLULAR CARCINOMA
    Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Mucosal Melanoma, Acral/Lentiginous Melanoma, Chronically Sun Damaged Melanomas
    Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
    University of Massachusetts Medical School
    Worcester, Massachusetts 01605
    Lung Cancer
    Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    Dana Farber Cancer Institute Deptof DanaFarberCancerInst(3)

    Trial Locations
    Dana Farber Cancer Institute Deptof DanaFarberCancerInst(3)
    Boston Medical Center StudyCoordinator:CLBH589B2201
    Cutaneous T-Cell Lymphoma
    Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Chronic Lymphocytic Leukemia
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Tufts Medical Center Cancer Center

    Trial Locations
    Tufts Medical Center Cancer Center
    Berkshire Hematology Oncology, PC
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Massachusetts General Hospital Cancer Center
    Boston Medical Center
    Brigham and Women's Hospital
    Tufts Medical Center
    Caritas Saint Elizabeth's Medical Center
    Lahey Clinic Medical Center
    Addison Gilbert Hospital
    Cape Cod Hospital
    Lowell General Hospital
    Norwood Hospital
    Berkshire Hematology Oncology PC
    Baystate Medical Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Floating Hospital for Children at Tufts - New England Medical Center

    Trial Locations
    Floating Hospital for Children at Tufts - New England Medical Center
    Massachusetts General Hospital
    UMASS Memorial Cancer Center - University Campus
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Massachusetts General Hospital
    Dana Farber / Brigham and Women's Cancer Center
    Glioblastoma Multiforme, Gliosarcoma